Pet Blood Pressure Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Veterinary Hospitals is the fastest growing sector, North America is the largest market

The Global Pet Blood Pressure Monitoring Devices Market is projected to expand from USD 140.11 Million in 2025 to USD 219.51 Million by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 7.77%. These veterinary medical instruments are specifically designed to measure arterial pressure in companion animals, employing either non-invasive oscillometric and Doppler techniques or invasive catheter-based methods to diagnose both hypertension and hypotension. This market's growth is primarily fueled by the increasing occurrence of age-related conditions, such as chronic kidney disease, and the rising trend of pet humanization, which collectively boost the demand for preventive diagnostics.

In 2024, the United States saw its dog population reach 89.7 million and its cat population climb to 73.8 million, according to the American Veterinary Medical Association, significantly broadening the potential patient base for these crucial diagnostic tools. Despite these strong growth drivers, the market faces a significant obstacle due to the accuracy challenges of measurements in clinical settings, primarily stemming from animal behavior. High anxiety levels in patients often result in the 'white-coat effect' or movement artifacts, which can distort readings and complicate the diagnosis of genuine pathological hypertension. This technical difficulty necessitates repeated confirmations and extensive staff training, potentially discouraging smaller veterinary practices from investing in or routinely utilizing these monitors.

Market Drivers

The escalating expenditure on veterinary healthcare serves as a significant impetus for the market, enhancing the accessibility of diagnostic instruments. As pet owners increasingly prioritize their animals' wellness, they demonstrate a greater willingness to invest in monitoring for chronic conditions, thereby enabling veterinary practices to implement superior blood pressure protocols. This financial commitment is evidenced by recent data from Synchrony's 'Pet Lifetime of Care Study' in June 2025, which reported the lifetime cost of care for a dog rising to between $22,125 and $60,602.

Such substantial dedication of capital directly supports the procurement of specialized monitoring devices, further reinforced by IDEXX Laboratories' 2025 report of a 7% organic growth in Companion Animal Group Diagnostics recurring revenue for the prior year, underscoring the global demand for clinical testing. Concurrently, the increasing adoption of pet insurance is actively dismantling financial barriers associated with ongoing disease management. Hypertension, for instance, requires regular screening, which often presents a recurring cost that uninsured clients may decline.

Insurance coverage ensures that veterinarians can adhere to best practice monitoring without owner resistance stemming from price concerns. This trend is clearly reflected in the North American Pet Health Insurance Association's 'State of the Industry Report' from April 2025, which indicated that the total premium volume in the U.S. reached $4.7 billion by the end of 2024. As coverage expands to include geriatric care, the utilization of blood pressure devices is progressively becoming a standard and reimbursed element of veterinary protocols.

Market Challenges

The primary obstacle hindering the expansion of the Global Pet Blood Pressure Monitoring Devices Market is the inherent unreliability of clinical measurements, which is largely attributed to animal behavior. Companion animals frequently experience heightened anxiety in veterinary environments, leading to phenomena such as the 'white-coat effect' or the presence of movement artifacts that produce inaccurate blood pressure readings. This technical volatility compels veterinary professionals to conduct repeated confirmations to accurately differentiate between stress-induced spikes and genuine pathological hypertension, a time-consuming process that significantly impedes clinical workflow and consumes valuable appointment slots.

Consequently, this diagnostic uncertainty diminishes the return on investment for smaller practices, which may not be able to absorb the operational delays associated with challenging patient handling or the costs of extensive staff training. According to the American Veterinary Medical Association, patient visits across veterinary practices saw a 2.3% decline in 2024 compared to the previous year, establishing an economic climate where operational efficiency is paramount. In this context, the time-intensive nature of acquiring accurate blood pressure data acts as a significant deterrent to widespread adoption, as clinics prioritize diagnostic tools that deliver immediate, reliable results without disrupting their carefully managed appointment schedules.

Market Trends

The market is increasingly prioritizing the development of species-specific diagnostic algorithms to mitigate inaccuracies caused by animal anxiety. Manufacturers are extensively utilizing large-scale datasets to refine oscillometric software, enabling devices to more precisely differentiate between genuine hypertension and stress-induced artifacts such as the 'white-coat effect'. This technological advancement is underpinned by substantial clinical research that validates these algorithms against invasive standards to ensure their reliability.

Notably, Mars Veterinary Health's 'Science Impact Report' from April 2025 highlighted the organization's contribution of over 450 peer-reviewed publications and facilitation of clinical trials across more than 140 locations, demonstrating the industry's widespread commitment to generating the rigorous data essential for optimizing these diagnostic tools for diverse veterinary patients. Concurrently, the integration of blood pressure data into veterinary telemedicine platforms is transforming the management workflows for chronic diseases.

This integration allows veterinarians to monitor hypertensive patients within their home environments, thereby obtaining representative 'resting' blood pressure values that are free from the stressors of a clinical setting. The feasibility of this remote care model is substantially supported by the growing population of insured pets, whose policies increasingly cover tele-triage and various digital health services. This trend is further substantiated by the North American Pet Health Insurance Association's 'State of the Industry Report' from April 2025, which confirmed that the total number of insured pets in North America reached 7.03 million by the end of 2024, indicating a robust user base ready for the adoption of connected monitoring solutions.

Key Market Players

• SunTech Medical Inc.
• CONTEC MEDICAL SYSTEMS CO.,LTD
• TOOTOO MEDITECH, CO., LTD
• New Gen Medical Systems
• Ramsay Health Care Limited
• Panlab, S.L.U
• KeeboMed Inc.
• AD Instruments NZ Limited.
• Shenzhen Mindray Animal Medical Technology Co., LTD.
• Midmark Corporation

Report Scope

In this report, the Global Pet Blood Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pet Blood Pressure Monitoring Devices Market, by Animal Type:

• Dogs
• Cats
• Other Pets

Pet Blood Pressure Monitoring Devices Market, by Product:

• Devices
• Consumables

Pet Blood Pressure Monitoring Devices Market, by Technology:

• Aneroid
• Automatic

Pet Blood Pressure Monitoring Devices Market, by End User:

• Veterinary Hospitals
• Veterinary Clinics
• Others

Pet Blood Pressure Monitoring Devices Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pet Blood Pressure Monitoring Devices Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.